Cognition Therapeutics, Inc. Other Current Liabilities
Cognition Therapeutics, Inc. (CGTX) had Other Current Liabilities of $78.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Other Liabilities, Current $78.00K.
- 2026-03-31: Other Liabilities, Current $194.00K.
- 2025-12-31: Other Liabilities, Current $307.00K.
- 2025-06-30: Other Liabilities, Current $41.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $78.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $194.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $307.00K 10-Q · filed 2026-08-07 | |
| 2025-06-30 | $41.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $161.00K 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $279.00K 10-K · filed 2026-03-26 | |
| 2024-06-30 | $185.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $366.00K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $544.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $2.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $217.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $427.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $634.00K 10-K · filed 2024-03-26 | |
| 2022-06-30 | $402.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $799.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $1.19M 10-K · filed 2023-03-23 | $1.95M 10-K · filed 2022-03-30 |
| 2021-09-30 | $913.00K 10-Q · filed 2021-11-17 | |
| 2020-12-31 | $253.00K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |